Intuitive Surgical (ISRG) Stock Forecast, Price Target & Predictions
ISRG Stock Forecast
Intuitive Surgical stock forecast is as follows: an average price target of $449.14 (represents a -18.43% downside from ISRG’s last price of $550.62) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.
ISRG Price Target
The average price target for Intuitive Surgical (ISRG) is $449.14 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $604.00 to $280.00. This represents a potential -18.43% downside from ISRG's last price of $550.62.
ISRG Analyst Ratings
According to 16 Wall Street analysts, Intuitive Surgical's rating consensus is 'Buy'. The analyst rating breakdown for ISRG stock is 0 'Strong Buy' (0.00%), 12 'Buy' (75.00%), 4 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Intuitive Surgical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 18, 2024 | David Roman | Goldman Sachs | $604.00 | $517.97 | 16.61% | 9.69% |
| Oct 18, 2024 | Shagun Singh | RBC Capital | $555.00 | $473.73 | 17.16% | 0.80% |
| Oct 18, 2024 | Adam Maeder | Piper Sandler | $538.00 | $473.73 | 13.57% | -2.29% |
| Oct 18, 2024 | Anthony Petrone | Mizuho Securities | $550.00 | $473.73 | 16.10% | -0.11% |
| Oct 18, 2024 | Rick Wise | Stifel Nicolaus | $525.00 | $473.73 | 10.82% | -4.65% |
| Oct 18, 2024 | Richard Newitter | Truist Financial | $570.00 | $473.73 | 20.32% | 3.52% |
| Oct 18, 2024 | Vijay Kumar | Evercore ISI | $490.00 | $473.73 | 3.43% | -11.01% |
| Oct 18, 2024 | Ryan Zimmerman | BTIG | $535.00 | $473.73 | 12.93% | -2.84% |
| Oct 15, 2024 | David Rescott | Robert W. Baird | $565.00 | $487.61 | 15.87% | 2.61% |
| Oct 15, 2024 | Larry Biegelsen | Wells Fargo | $466.00 | $487.61 | -4.43% | -15.37% |
The latest Intuitive Surgical stock forecast, released on Oct 18, 2024 by David Roman from Goldman Sachs, set a price target of $604.00, which represents a 16.61% increase from the stock price at the time of the forecast ($517.97), and a 9.69% increase from ISRG last price ($550.62).
Intuitive Surgical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 14 | 27 |
| Avg Price Target | - | $534.00 | $494.56 |
| Last Closing Price | $550.62 | $550.62 | $550.62 |
| Upside/Downside | -100.00% | -3.02% | -10.18% |
In the current month, the average price target of Intuitive Surgical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Intuitive Surgical's last price of $550.62. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 18, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Oct 18, 2024 | Oppenheimer | Perform | Perform | Hold |
| Oct 18, 2024 | Evercore ISI | Cautious | Cautious | Hold |
| Oct 15, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Oct 14, 2024 | Raymond James | Outperform | Outperform | Hold |
| Oct 14, 2024 | BTIG | Buy | Buy | Hold |
| Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Oct 01, 2024 | Evercore ISI | Positive | Positive | Hold |
| Aug 28, 2024 | BTIG | Buy | Buy | Hold |
| Aug 22, 2024 | Citigroup | Buy | Buy | Hold |
Intuitive Surgical's last stock rating was published by Piper Sandler on Oct 18, 2024. The company gave ISRG a "Overweight" rating, the same as its previous rate.
Intuitive Surgical Financial Forecast
Intuitive Surgical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.93B | $1.74B | $1.76B | $1.70B | $1.66B | $1.56B | $1.52B | $1.49B | $1.55B | $1.40B | $1.46B | $1.29B | $1.33B | $1.08B | $852.10M | $1.10B | $1.28B | $1.13B |
| Avg Forecast | $2.92B | $2.75B | $2.70B | $2.54B | $2.57B | $2.39B | $2.34B | $2.20B | $2.20B | $2.01B | $1.97B | $1.87B | $1.89B | $1.77B | $1.74B | $1.59B | $1.52B | $1.52B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| High Forecast | $2.98B | $2.81B | $2.76B | $2.59B | $2.62B | $2.44B | $2.39B | $2.24B | $2.26B | $2.01B | $1.97B | $1.87B | $1.93B | $1.81B | $1.78B | $1.63B | $1.60B | $1.52B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| Low Forecast | $2.82B | $2.66B | $2.61B | $2.45B | $2.48B | $2.31B | $2.27B | $2.12B | $2.09B | $2.01B | $1.97B | $1.87B | $1.83B | $1.71B | $1.68B | $1.54B | $1.45B | $1.52B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 17 | 15 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.99% | 1.01% | 1.06% | 1.09% | 1.02% | 0.98% | 1.04% | 1.02% | 1.01% | 1.15% | 1.16% | 1.06% | 1.11% | 1.27% | 1.05% | 1.04% | 1.06% |
Intuitive Surgical's average Quarter revenue forecast for Mar 24 based on 10 analysts is $1.87B, with a low forecast of $1.87B, and a high forecast of $1.87B. ISRG's average Quarter revenue forecast represents a -3.01% decrease compared to the company's last Quarter revenue of $1.93B (Dec 23).
Intuitive Surgical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 17 | 15 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $573.40M | $465.80M | $463.20M | $387.60M | $372.50M | $398.90M | $397.60M | $408.10M | $533.00M | $536.40M | $596.00M | $511.60M | $517.90M | $421.50M | $168.80M | $368.80M | $490.50M | $448.00M |
| Avg Forecast | $850.04M | $801.74M | $787.03M | $739.16M | $747.56M | $696.36M | $682.37M | $640.08M | $641.44M | $584.08M | $574.21M | $550.10M | $549.92M | $515.46M | $507.18M | $500.09M | $577.14M | $434.99M | $445.49M | $454.63M | $434.36M | $395.23M | $361.85M | $338.47M | $356.61M | $277.19M | $191.66M | $347.02M | $351.46M | $304.41M |
| High Forecast | $868.68M | $819.32M | $804.29M | $755.37M | $763.96M | $711.64M | $697.34M | $651.88M | $659.02M | $584.09M | $574.21M | $660.12M | $561.98M | $526.77M | $518.31M | $600.11M | $692.57M | $434.99M | $445.49M | $545.56M | $434.36M | $395.23M | $361.85M | $406.17M | $356.61M | $277.19M | $191.66M | $416.42M | $351.46M | $304.41M |
| Low Forecast | $822.12M | $775.41M | $761.18M | $714.88M | $723.01M | $673.49M | $659.96M | $616.48M | $609.22M | $584.07M | $574.21M | $440.08M | $531.86M | $498.53M | $490.53M | $400.07M | $461.71M | $434.99M | $445.49M | $363.70M | $434.36M | $395.23M | $361.85M | $270.78M | $356.61M | $277.19M | $191.66M | $277.62M | $351.46M | $304.41M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 0.90% | 0.91% | 0.78% | 0.65% | 0.92% | 0.89% | 0.90% | 1.23% | 1.36% | 1.65% | 1.51% | 1.45% | 1.52% | 0.88% | 1.06% | 1.40% | 1.47% |
10 analysts predict ISRG's average Quarter EBITDA for Mar 24 to be $550.10M, with a high of $660.12M and a low of $440.08M. This is -4.06% lower than Intuitive Surgical's previous annual EBITDA (Dec 23) of $573.40M.
Intuitive Surgical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 17 | 15 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $606.20M | $415.70M | $420.80M | $355.30M | $324.90M | $324.00M | $307.80M | $365.60M | $382.70M | $380.50M | $517.20M | $426.30M | $365.20M | $313.90M | $68.00M | $313.50M | $357.70M | $396.80M |
| Avg Forecast | $867.71M | $849.35M | $827.71M | $746.15M | $751.24M | $731.44M | $714.30M | $644.85M | $635.12M | $595.60M | $559.23M | $421.90M | $538.23M | $513.47M | $482.15M | $383.54M | $412.12M | $409.59M | $432.19M | $348.67M | $461.55M | $420.77M | $369.95M | $282.04M | $375.99M | $247.94M | $64.12M | $294.99M | $406.44M | $359.88M |
| High Forecast | $892.45M | $873.57M | $851.30M | $767.42M | $772.65M | $752.29M | $734.66M | $662.96M | $667.60M | $613.87M | $559.26M | $506.27M | $560.20M | $518.47M | $495.90M | $460.25M | $494.54M | $409.59M | $439.88M | $418.41M | $461.55M | $435.16M | $372.40M | $338.45M | $375.99M | $247.94M | $64.12M | $353.98M | $406.44M | $359.88M |
| Low Forecast | $830.66M | $813.09M | $792.37M | $714.29M | $719.16M | $700.21M | $683.80M | $623.11M | $602.64M | $577.33M | $559.20M | $337.52M | $512.60M | $508.47M | $461.56M | $306.83M | $329.69M | $409.59M | $424.51M | $278.94M | $461.55M | $406.37M | $367.50M | $225.63M | $375.99M | $247.94M | $64.12M | $235.99M | $406.44M | $359.88M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 0.81% | 0.87% | 0.93% | 0.79% | 0.79% | 0.71% | 1.05% | 0.83% | 0.90% | 1.40% | 1.51% | 0.97% | 1.27% | 1.06% | 1.06% | 0.88% | 1.10% |
Intuitive Surgical's average Quarter net income forecast for Mar 24 is $421.90M, with a range of $337.52M to $506.27M. ISRG's average Quarter net income forecast represents a -30.40% decrease compared to the company's last Quarter net income of $606.20M (Dec 23).
Intuitive Surgical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 17 | 15 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $567.10M | $452.00M | $464.30M | $480.50M | $494.30M | $436.10M | $418.40M | $391.10M | $427.00M | $363.30M | $350.20M | $326.00M | $330.20M | $298.90M | $279.10M | $308.10M | $341.80M | $284.00M |
| Avg Forecast | $790.56M | $745.64M | $731.96M | $687.44M | $695.26M | $647.64M | $634.63M | $595.29M | $596.56M | $543.21M | $534.03M | $451.32M | $511.44M | $479.39M | $471.70M | $410.29M | $462.36M | $412.73M | $422.69M | $372.99M | $412.13M | $375.00M | $343.34M | $215.68M | $338.37M | $263.00M | $181.85M | $289.91M | $333.47M | $288.84M |
| High Forecast | $807.90M | $761.99M | $748.01M | $702.51M | $710.51M | $661.84M | $648.55M | $606.27M | $612.90M | $543.22M | $534.03M | $541.59M | $522.66M | $489.91M | $482.04M | $492.35M | $554.83M | $412.73M | $422.69M | $447.59M | $412.13M | $375.00M | $343.34M | $258.82M | $338.37M | $263.00M | $181.85M | $347.89M | $333.47M | $288.84M |
| Low Forecast | $764.60M | $721.15M | $707.92M | $664.86M | $672.42M | $626.37M | $613.78M | $573.35M | $566.60M | $543.20M | $534.03M | $361.06M | $494.65M | $463.65M | $456.20M | $328.23M | $369.89M | $412.73M | $422.69M | $298.39M | $412.13M | $375.00M | $343.34M | $172.54M | $338.37M | $263.00M | $181.85M | $231.92M | $333.47M | $288.84M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 0.94% | 0.98% | 1.17% | 1.07% | 1.06% | 0.99% | 1.05% | 1.04% | 0.97% | 1.02% | 1.51% | 0.98% | 1.14% | 1.53% | 1.06% | 1.02% | 0.98% |
Intuitive Surgical's average Quarter SG&A projection for Mar 24 is $451.32M, based on 10 Wall Street analysts, with a range of $361.06M to $541.59M. The forecast indicates a -20.42% fall compared to ISRG last annual SG&A of $567.10M (Dec 23).
Intuitive Surgical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 17 | 15 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.18 | $1.20 | $1.01 | $0.93 | $0.91 | $0.86 | $1.02 | $1.07 | $1.07 | $1.45 | $1.20 | $1.04 | $0.89 | $0.19 | $0.90 | $1.03 | $1.15 |
| Avg Forecast | $2.39 | $2.34 | $2.28 | $2.06 | $2.07 | $2.02 | $1.97 | $1.78 | $1.75 | $1.64 | $1.54 | $1.42 | $1.48 | $1.42 | $1.33 | $1.20 | $1.13 | $1.13 | $1.20 | $1.08 | $1.28 | $1.17 | $1.02 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| High Forecast | $2.46 | $2.41 | $2.35 | $2.12 | $2.13 | $2.07 | $2.03 | $1.83 | $1.84 | $1.69 | $1.54 | $1.42 | $1.54 | $1.43 | $1.37 | $1.23 | $1.19 | $1.13 | $1.22 | $1.08 | $1.28 | $1.21 | $1.03 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| Low Forecast | $2.29 | $2.24 | $2.18 | $1.97 | $1.98 | $1.93 | $1.89 | $1.72 | $1.66 | $1.59 | $1.54 | $1.42 | $1.41 | $1.40 | $1.27 | $1.15 | $1.08 | $1.13 | $1.18 | $1.08 | $1.28 | $1.13 | $1.02 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | 0.90% | 0.84% | 0.82% | 0.80% | 0.72% | 0.95% | 0.84% | 0.92% | 1.42% | 1.36% | 1.00% | 1.30% | 1.09% | 1.02% | 0.91% | 1.15% |
According to 11 Wall Street analysts, Intuitive Surgical's projected average Quarter EPS for Dec 23 is $1.48, with a low estimate of $1.41 and a high estimate of $1.54. This represents a 25.76% increase compared to ISRG previous annual EPS of $1.18 (Sep 23).
Intuitive Surgical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BNGO | Bionano Genomics | $0.22 | $59.33 | 26868.18% | Buy |
| COO | Cooper Companies | $99.91 | $298.00 | 198.27% | Buy |
| BAX | Baxter | $32.99 | $60.38 | 83.03% | Hold |
| TFX | Teleflex | $190.64 | $304.36 | 59.65% | Buy |
| RGEN | Repligen | $141.76 | $193.86 | 36.75% | Buy |
| BDX | Becton, Dickinson and Company | $225.45 | $283.27 | 25.65% | Buy |
| HOLX | Hologic | $78.72 | $80.21 | 1.89% | Buy |
| ICUI | ICU Medical | $168.84 | $172.00 | 1.87% | Buy |
| MMSI | Merit Medical Systems | $105.03 | $100.78 | -4.05% | Buy |
| WST | West Pharmaceutical Services | $320.88 | $297.67 | -7.23% | Buy |
| RMD | ResMed | $243.60 | $219.13 | -10.05% | Hold |
| EMBC | Embecta | $14.00 | $12.00 | -14.29% | Sell |
| ISRG | Intuitive Surgical | $550.62 | $449.14 | -18.43% | Buy |